Related references
Note: Only part of the references are listed.Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification
Matteo Brunelli et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Toward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging
Heng Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis
Gulisa Turashvili et al.
BMC CANCER (2009)
HER-2/neu expression in primary and metastatic breast cancer
Elyse E. Lower et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer
Michelle Longmire et al.
CANCER SCIENCE (2009)
Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
Chirayu Shah et al.
CLINICAL CANCER RESEARCH (2009)
Associations between the uptake of In-111-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts
Kristin McLarty et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI
Ting-Jung Chen et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
Anna Orlova et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Fluorophore-Quencher Based Activatable Targeted Optical Probes for Detecting in Vivo Cancer Metastases
Mikako Ogawa et al.
MOLECULAR PHARMACEUTICS (2009)
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway
David L. Morse et al.
NMR IN BIOMEDICINE (2009)
Protein kinase inhibitors: contributions from structure to clinical compounds
Louise N. Johnson
QUARTERLY REVIEWS OF BIOPHYSICS (2009)
Slow internalization of anti-HER2 synthetic Affibody monomer 111In-DOTA-ZHER2:342-pep2:: Implications for development of labeled tracers
Helena Wallberg et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging
Sang Bong Lee et al.
CLINICAL CANCER RESEARCH (2008)
Quantitative correlation between sonographic textural feature and histopathological components for breast cancer: preliminary results
Shao-Jer Chen et al.
CLINICAL IMAGING (2008)
Near infrared fluorescent optical imaging for nodal staging
Lakshmi Sampath et al.
JOURNAL OF BIOMEDICAL OPTICS (2008)
Small-animal PET Imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules
Zhen Cheng et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach
Wenlian Zhu et al.
MAGNETIC RESONANCE IN MEDICINE (2008)
Human breast cancer tumor models:: Molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy
Michael S. Gee et al.
RADIOLOGY (2008)
[18F]FBEM-ZHER2:342 -: Affibody molecule -: a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography
Gabriela Kramer-Marek et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
The HER family and cancer: emerging molecular mechanisms and therapeutic targets
Natalia V. Sergina et al.
TRENDS IN MOLECULAR MEDICINE (2007)
In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies
Yoshinori Koyama et al.
NEOPLASIA (2007)
In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies
Tristan Barrett et al.
CLINICAL CANCER RESEARCH (2007)
99mTc-maEEE-ZHER2:342, an affibody molecule-based tracer for the detection of HER2 expression in malignant tumors
Thuy Tran et al.
BIOCONJUGATE CHEMISTRY (2007)
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer
Lakshmi Sampath et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro
Jun Liu et al.
PHYSICS IN MEDICINE AND BIOLOGY (2007)
Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu
Yoshinori Koyama et al.
CLINICAL CANCER RESEARCH (2007)
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Patrick J. Perik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
DM Goldenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals
YM Huh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET
E Mume et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
[methyl-3H]Choline incorporation into MCF7 tumour cells:: correlation with proliferation
F Al-Saeedi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [99mTc]-HYNIC-trastuzumab (Herceptin) Fab fragments
Y Tang et al.
NUCLEAR MEDICINE COMMUNICATIONS (2005)
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata et al.
CANCER CELL (2004)
The C-neu mammary carcinoma in Oncomice;: characterization and monitoring response to treatment with herceptin by magnetic resonance methods
LM Rodrigues et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2004)
Structural basis for recognition by an in vitro evolved affibody
M Högbom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles
D Artemov et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Biological effects of anti-ErbB2 single chain antibodies selected for internalizing function
RM Neve et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer:: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
G Pauletti et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
